`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`MYLAN PHARMACEUTICALS INC.
`Petitioner,
`
`v.
`
`3M COMPANY
`Patent Owner.
`
`U.S. Patent No. 6,743,413 to Schultz et al.
`Issue Date: June 1, 2004
`Title: Suspension Aerosol Formulations
`
`_____________________
`
`Inter Partes Review No.: IPR2015-_____
`
`
`
`Petitioner’s Exhibit List
`for Inter Partes Review of U.S. Patent No. 6,743,413
`Under 35 U.S.C. §§ 311-319 and 37 C.F.R. §§ 42.1-.80, 42.100-.123
`
`
`
`
`
`
`
`
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`
`
`
`Exhibit
`#
`
`Petitioner’s Exhibit List
`
`Description
`
`1001
`
`U.S. Patent No. 6,743,413
`
`1002
`
`U.S. Patent Application Ser. No. 07/809,791
`
`1003
`
`U.S. Patent Application Ser. No. 07/810,401
`
`1004
`
`December 8, 1998 Request that an Interference Be Declared
`
`1005
`
`July 30, 2002 Amendment
`
`1007
`
`International Patent Application Publication No. WO 1991/004011
`
`1008
`
`RESERVED
`
`1009
`
`U.S. Patent No. 4,866,051
`
`1010
`
`Weir, D.C., et al. “Corticosteroid trials in non-asthmatic chronic
`airflow obstruction: a comparison of oral prednisolone and inhaled
`beclomethasone dipropionate.” Thorax 1990;45:112-117
`
`1011
`
`International Patent Application Publication No. WO 1990/007333
`
`1012
`
`Curriculum Vitae of Hugh Smyth
`
`1013
`
`RESERVED
`
`1014
`
`1015
`
`Joseph P. Remington, Remington’s Pharmaceutical Sciences 308-17
`(Alfonso R. Gennaro ed., 17 ed. 1985)
`
`G. S. Banker and C. T. Rhodes, Eds., Modern Pharmaceutics,
`Second Edition 341 (Marcel Dekker, Inc., New York 1990)